Guest guest Posted December 6, 2006 Report Share Posted December 6, 2006 Access denied to crucial new hiv/aids medicines: INP+ The Imphal Free Press/KanglaOnline, India - 29 Nov 2006 New Delhi, Dec 29: Over 200 persons living with HIV gathered in the capital today to start off a three day dharna at Jantar Mantar to demand that the Government of India provide new AIDS drugs (second line treatment) to those who need it. The dharna is being organized by the Indian Network for People living with HIV/AIDS (INP+) and the Delhi Network of Positive People (DNP+) and will culminate in a mass rally at Jantar Mantar on the 1st of December World AIDS Day. " Under the government programme people living with HIV/AIDS in India cannot get new or improved drugs that can make a critical difference in saving our lives " , says Loon Gangte, President of DNP +. According to medical experts patients need to be switched to a newer `second-line` drug regimens after a few years when resistance/toxicity naturally develops to their first set of medications. The World Health Organization (WHO) in August 2006 updated its anti-retroviral guidelines for HIV/AIDS treatment in developing countries and recommends newer AIDS drugs like tenofovir (TDF), lopinavir/ritonavir for first and second-line regimens. " It`s a cruel irony that although Indian pharmaceutical companies are producing new AIDS drugs like Tenofovir and Lopinavir/Ritonavir recommended by the WHO, these drugs are being exported but are not being made available in government treatment centres here. " says Elango Ramachandar President of INP+. There are approximately 44,000 people receiving anti-retroviral treatment (ART) from the government. Government of India started implementing its free AIDS treatment programme in 2004 and now has several patients who are in urgent need of the newer `second-line` drugs, says K.K. Abraham of INP+. He added, " patients who need second line treatment are experiencing a drastic decrease in their CD4 counts, an increase in the viral load in the bodies and continuous weight loss. If the government does not act soon, it will be too late for many of us. " " For many of us, if we cannot access second line ARV drugs now, many of us will not be there to witness the next World AIDS Day, " said Umashankar Pandey who has come from Kachh in Gujarat to take part in the Dharna at Jantar Mantar. 20 people living with HIV/AIDS from various states who are now in critical need of the newer second line AIDS drugs will sit on the dharna against the resistance and refusal of the National AIDS Control Organisation to provide the newer AIDS drugs. The Government has often used the excuse of the cost of second line AIDS drugs to rebuff demands for its free provision through the ARV rollout programme. Networks of HIV-positive persons find this argument unacceptable. " We have taken on legal battles against patent applications by big pharma on these drugs to make sure that newer AIDS drugs are not patented and continue to be affordable and accessible for the common person, but what has the government done to make sure people can get these drugs? " asks Loon Gangte, from the DNP+. The dharna was inaugurated by Dr. Karan Singh Yadav, Member of Parliament and Vice Chairperson of the Indian Medical Parliamentarians Forum and was addressed by S. Sudhakar Reddy (Member of Parliament), Elango Ramachandar of INP+, Loon Gangte of DNP+ as well as other PLHA leaders, activists and social workers representing various organizations. The Imphal Free Press http://www.kanglaonline.com/index.php?template=headline & newsid=35103 & typeid=1 ____________________________ Leena Menghaney Campaign for Access to Essential Medicines Medecins Sans Frontieres - Holland (in India) Tel: 9811365412, +91 11 24337225, + 91 1151552413 Fax: +91 11 24336834 E-mail: msfh-india-medco-assist@... Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.